Larvol Delta - iTeos-Reports-Topline-Interim-Results-from-GALAXIES-Lung201-Study-of-Belrestotug--Dostarlimab-in-FirstLine-PDL1-High-NonSmall-Cell-Lung-Cancer-Patients

belrestotug (EOS-448) - iTeos, GSK

https://www.globenewswire.com/news-release/2025/05/13/3080020/0/en/iTeos-Reports-Topline-Interim-Results-from-GALAXIES-Lung-201-Study-of-Belrestotug-Dostarlimab-in-First-Line-PD-L1-High-Non-Small-Cell-Lung-Cancer-Patients.html

May 13, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next